CONMED Corporation

CNMD ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2009
Operating Activities
Net Income $12.1M
Depreciation & Amortization —
Depreciation $18.7M
Amortization —
Stock-Based Compensation $4.3M
Net Cash from Operating Activities $25.0M
Investing Activities
Capital Expenditures $21.4M
Business Acquisitions —
Net Cash from Investing Activities $-21.8M
Financing Activities
Dividends Paid —
Stock Repurchases $0
Net Cash from Financing Activities $-3.7M
Net Change in Cash $-1.7M
Free Cash Flow $3.6M
← Newer Page 3 of 3 Older →